Clinical Trials Insight: 700045741

Trial Profile

Clinical Trials Insight: 700045741

Phase of Trial: Phase II

Latest Information Update: 09 Jun 2009

At a glance

  • Drugs Daclizumab; Rindopepimut; Temozolomide
  • Indications Glioblastoma
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 09 Jun 2009 New trial record.
    • 31 May 2009 Preliminary data were presented in a poster session at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO), according to a Pfizer media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top